B cell depletion in autoimmune diabetes: insights from murine models

Bibliography

• Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996;15:291-7
   Google Scholar
• Phillips JM, Parish NM, Bland C, Type 1 diabetes development requires both CD4+ and CD8+ T cells and can be reversed by non-depleting antibodies targeting both T cell populations. Rev Diabet Stud 2009;6:97-103
   PubMedGoogle Scholar
• Herold KC, Gitelman SE, Masharani U, A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 2005;54:1763-9
   PubMed Web of Science ®Google Scholar
• Keymeulen B, Walter M, Mathieu C, Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. Diabetologia 2010;53:614-23
   PubMed Web of Science ®Google Scholar
• Weiner GJ. Rituximab: mechanism of action. Semin Hematol 2010;47:115-23
   PubMed Web of Science ®Google Scholar
• Bouaziz JD, Yanaba K, Venturi GM, Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc Natl Acad Sci USA 2007;104:20878-83
   PubMed Web of Science ®Google Scholar
• Cohen SB, Emery P, Greenwald MW, Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 2006;54:2793-806
   PubMed Web of Science ®Google Scholar
• Joly P, Mouquet H, Roujeau JC, A single cycle of rituximab for the treatment of severe pemphigus. N Engl J Med 2007;357:545-52
   PubMed Web of Science ®Google Scholar
• Hauser SL, Waubant E, Arnold DL, B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008;358:676-88
   PubMed Web of Science ®Google Scholar
• Signore A, Pozzilli P, Gale EA, The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia 1989;32:282-9
   PubMed Web of Science ®Google Scholar
• Jarpe AJ, Hickman MR, Anderson JT, Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes. Reg Immunol 1990;3:305-17
   PubMedGoogle Scholar
• Dean BM, Walker R, Bone AJ, Pre-diabetes in the spontaneously diabetic BB/E rat: lymphocyte subpopulations in the pancreatic infiltrate and expression of rat MHC class II molecules in endocrine cells. Diabetologia 1985;28:464-6
   PubMed Web of Science ®Google Scholar
• Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats. Diabetologia 1989;32:126-34
   PubMed Web of Science ®Google Scholar
• Clough LE, Wang CJ, Schmidt EM, Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21. J Immunol 2008;180:5393-401
   PubMed Web of Science ®Google Scholar
• Wesley JD, Sather BD, Perdue NR, Cellular requirements for diabetes induction in DO11.10×RIPmOVA mice. J Immunol 2010;185:4760-8
   PubMedGoogle Scholar
• Bottazzo GF, Dean BM, McNally JM, In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985;313:353-60
   PubMed Web of Science ®Google Scholar
• Willcox A, Richardson SJ, Bone AJ, Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2009;155:173-81
   PubMed Web of Science ®Google Scholar
• Charlton B, Zhang MD, Slattery RM. B lymphocytes not required for progression from insulitis to diabetes in non-obese diabetic mice. Immunol Cell Biol 2001;79:597-601
   PubMedGoogle Scholar
• Chiu PP, Serreze DV, Danska JS. Development and function of diabetogenic T-cells in B-cell-deficient nonobese diabetic mice. Diabetes 2001;50:763-70
   PubMed Web of Science ®Google Scholar
• Sarween N, Chodos A, Raykundalia C, CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J Immunol 2004;173:2942-51
   PubMed Web of Science ®Google Scholar
• Serreze DV, Chapman HD, Varnum DS, B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new “speed congenic” stock of NODIg mu null mice. J Exp Med 1996;184:2049-53
   PubMed Web of Science ®Google Scholar
• Akashi T, Nagafuchi S, Anzai K, Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int Immunol 1997;9:1159-64
   PubMed Web of Science ®Google Scholar
• Yang M, Charlton B, Gautam AM. Development of insulitis and diabetes in B cell-deficient NOD mice. J Autoimmun 1997;10:257-60
   PubMed Web of Science ®Google Scholar
• Wong FS, Visintin I, Wen L, The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice. J Exp Med 1998;187:1985-93
   PubMed Web of Science ®Google Scholar
• Silveira PA, Johnson E, Chapman HD, The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur J Immunol 2002;32:3657-66
   PubMed Web of Science ®Google Scholar
• Martin S, Wolf-Eichbaum D, Duinkerken G, Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med 2001;345:1036-40
   PubMed Web of Science ®Google Scholar
• Forsgren S, Andersson A, Hillorn V, Immunoglobulin-mediated prevention of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Scand J Immunol 1991;34:445-51
   PubMed Web of Science ®Google Scholar
• Noorchashm H, Noorchashm N, Kern J, B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 1997;46:941-6
   PubMed Web of Science ®Google Scholar
• Xiu Y, Wong CP, Bouaziz JD, B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in FcgammaR effector functions. J Immunol 2008;180:2863-75
   PubMed Web of Science ®Google Scholar
• Fiorina P, Vergani A, Dada S, Targeting CD22 reprograms B-cells and reverses autoimmune diabetes. Diabetes 2008;57:3013-24
   PubMed Web of Science ®Google Scholar
• Hu CY, Rodriguez-Pinto D, Du W, Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest 2007;117:3857-67
   PubMed Web of Science ®Google Scholar
• Marino E, Villanueva J, Walters S, CD4+CD25+ T-cells control autoimmunity in the absence of B-cells. Diabetes 2009;58:1568-77
   PubMed Web of Science ®Google Scholar
• Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 2009;361:2143-52
   PubMed Web of Science ®Google Scholar
• Verge CF, Gianani R, Kawasaki E, Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J Autoimmun 1996;9:379-83
   PubMed Web of Science ®Google Scholar
• Taplin CE, Barker JM. Autoantibodies in type 1 diabetes. Autoimmunity 2008;41:11-18
   PubMed Web of Science ®Google Scholar
• Jaeger C, Brendel MD, Eckhard M, Islet autoantibodies as potential markers for disease recurrence in clinical islet transplantation. Exp Clin Endocrinol Diabetes 2000;108:328-33
   PubMedGoogle Scholar
• Robles DT, Eisenbarth GS, Dailey NJ, Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice. Diabetes 2003;52:882-6
   PubMedGoogle Scholar
• Harbers SO, Crocker A, Catalano G, Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance J Clin Invest 2007;117:1361-9
   PubMedGoogle Scholar
• Hulbert C, Riseili B, Rojas M, B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice. J Immunol 2001;167:5535-8
   PubMed Web of Science ®Google Scholar
• Greeley SA, Katsumata M, Yu L, Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med 2002;8:399-402
   PubMed Web of Science ®Google Scholar
• Serreze DV, Fleming SA, Chapman HD, B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 1998;161:3912-18
   PubMed Web of Science ®Google Scholar
• Ryan GA, Wang CJ, Chamberlain JL, B1 cells promote pancreas infiltration by autoreactive T cells. J Immunol 2010;185:2800-7
   PubMed Web of Science ®Google Scholar
• Levesque MC, St Clair EW. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse. J Allergy Clin Immunol 2008;121:13-21; quiz 22-23
   PubMed Web of Science ®Google Scholar
• Taylor RP, Lindorfer MA. Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies. Curr Opin Immunol 2008;20:444-9
   PubMed Web of Science ®Google Scholar
• Koczwara K, Ziegler AG, Bonifacio E. Maternal immunity to insulin does not affect diabetes risk in progeny of non obese diabetic mice. Clin Exp Immunol 2004;136:56-9
   PubMedGoogle Scholar
• Warram JH, Krolewski AS, Gottlieb MS, Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 1984;311:149-52
   PubMed Web of Science ®Google Scholar
• Wong FS, Wen L, Tang M, Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes 2004;53:2581-7
   PubMed Web of Science ®Google Scholar
• Lanzavecchia A. Antigen uptake and accumulation in antigen-specific B cells. Immunol Rev 1987;99:39-51
   PubMed Web of Science ®Google Scholar
• Crawford A, Macleod M, Schumacher T, Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J Immunol 2006;176:3498-506
   PubMed Web of Science ®Google Scholar
• Carrasco YR, Batista FD. B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity 2007;27:160-71
   PubMed Web of Science ®Google Scholar
• Pape KA, Catron DM, Itano AA, The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity 2007;26:491-502
   PubMed Web of Science ®Google Scholar
• Phan TG, Grigorova I, Okada T, Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol 2007;8:992-1000
   PubMed Web of Science ®Google Scholar
• Yan J, Harvey BP, Gee RJ, B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation. J Immunol 2006;177:4481-7
   PubMed Web of Science ®Google Scholar
• Zhong G, Reis e Sousa C, Germain RN. Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro. J Exp Med 1997;186:673-82
   PubMedGoogle Scholar
• Falcone M, Lee J, Patstone G, B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol 1998;161:1163-8
   PubMed Web of Science ®Google Scholar
• Greeley SA, Moore DJ, Noorchashm H, Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice. J Immunol 2001;167:4351-7
   PubMed Web of Science ®Google Scholar
• Noorchashm H, Lieu YK, Noorchashm N, I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol 1999;163:743-50
   PubMed Web of Science ®Google Scholar
• Wong FS, Wen L. B cells in autoimmune diabetes. Rev Diabet Stud 2005;2:121-35
   PubMedGoogle Scholar
• Kendall PL, Yu G, Woodward EJ, Tertiary lymphoid structures in the pancreas promote selection of B lymphocytes in autoimmune diabetes. J Immunol 2007;178:5643-51
   PubMed Web of Science ®Google Scholar
• Golovkina TV, Shlomchik M, Hannum L, Organogenic role of B lymphocytes in mucosal immunity. Science 1999;286:1965-8
   Google Scholar
• Endres R, Alimzhanov MB, Plitz T, Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells. J Exp Med 1999;189:159-68
   PubMed Web of Science ®Google Scholar
• Fu YX, Huang G, Wang Y, B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion. J Exp Med 1998;187:1009-18
   PubMed Web of Science ®Google Scholar
• Ngo VN, Cornall RJ, Cyster JG. Splenic T zone development is B cell dependent. J Exp Med 2001;194:1649-60
   PubMed Web of Science ®Google Scholar
• Brodie GM, Wallberg M, Santamaria P, B cells promote intra-islet CD8+ cytotoxic T lymphocyte survival to enhance type 1. Diabetes 2008;57:909-17
   PubMed Web of Science ®Google Scholar
• Chen X, Martin F, Forbush KA, Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol 1997;9:27-41
   PubMedGoogle Scholar
• Murakami M, Tsubata T, Okamoto M, Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 1992;357:77-80
   PubMed Web of Science ®Google Scholar
• Martin F, Kearney JF. Marginal-zone B cells. Nat Rev Immunol 2002;2:323-35
   PubMed Web of Science ®Google Scholar
• Attanavanich K, Kearney JF. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol 2004;172:803-11
   PubMed Web of Science ®Google Scholar
• Cinamon G, Zachariah MA, Lam OM, Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol 2008;9:54-62
   PubMed Web of Science ®Google Scholar
• MacLennan IC, Gray D, Kumararatne DS, The lymphocytes of splenic marginal zones: a distinct B-cell lineage. Immunol Today 1982;3:305-7
   PubMedGoogle Scholar
• Segundo C, Rodriguez C, Garcia-Poley A, Thyroid-infiltrating B lymphocytes in Graves' disease are related to marginal zone and memory B cell compartments. Thyroid 2001;11:525-30
   PubMedGoogle Scholar
• Groom J, Kalled SL, Cutler AH, Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest 2002;109:59-68
   PubMed Web of Science ®Google Scholar
• Rolf J, Motta V, Duarte N, The enlarged population of marginal zone/CD1d(high) B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11. J Immunol 2005;174:4821-7
   PubMed Web of Science ®Google Scholar
• Quinn WJ III, Noorchashm N, Crowley JE, Cutting edge: impaired transitional B cell production and selection in the nonobese diabetic mouse. J Immunol 2006;176:7159-64
   PubMed Web of Science ®Google Scholar
• Marino E, Batten M, Groom J, Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes 2008;57:395-404
   PubMed Web of Science ®Google Scholar
• Brodnicki TC, O'Donnell K, Quirk F, Congenic nonobese diabetic mouse strains fail to confirm linkage of a marginal zone B lymphocyte phenotype to the Idd11 locus on chromosome 4. J Immunol 2006;176:701-2; author reply 702
   PubMed Web of Science ®Google Scholar
• Silveira PA, Chapman HD, Stolp J, Genes within the Idd5 and Idd9/11 diabetes susceptibility loci affect the pathogenic activity of B cells in nonobese diabetic mice. J Immunol 2006;177:7033-41
   PubMed Web of Science ®Google Scholar
• Kendall PL, Woodward EJ, Hulbert C, Peritoneal B cells govern the outcome of diabetes in non-obese diabetic mice. Eur J Immunol 2004;34:2387-95
   PubMed Web of Science ®Google Scholar
• Hayakawa K, Hardy RR. Normal, autoimmune, and malignant CD5+ B cells: the Ly-1 B lineage? Annu Rev Immunol 1988;6:197-218
   PubMed Web of Science ®Google Scholar
• Herzenberg LA, Tung JW. B cell lineages: documented at last! Nat Immunol 2006;7:225-6
   PubMedGoogle Scholar
• Becker H, Weber C, Storch S, Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity. Clin Immunol Immunopathol 1990;56:219-25
   PubMedGoogle Scholar
• Youinou P, Mackenzie L, Katsikis P, The relationship between CD5-expressing B lymphocytes and serologic abnormalities in rheumatoid arthritis patients and their relatives. Arthritis Rheum 1990;33:339-48
   PubMed Web of Science ®Google Scholar
• Murakami M, Yoshioka H, Shirai T, Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int Immunol 1995;7:877-82
   PubMed Web of Science ®Google Scholar
• Hayakawa K, Hardy RR, Honda M, Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci USA 1984;81:2494-8
   PubMed Web of Science ®Google Scholar
• Pao LI, Lam KP, Henderson JM, B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity 2007;27:35-48
   PubMed Web of Science ®Google Scholar
• Nakashima H, Hamaguchi Y, Watanabe R, CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions. J Immunol 2010;184:4637-45
   PubMedGoogle Scholar
• Hussain S, Delovitch TL. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis. J Immunol 2005;174:680-7
   PubMedGoogle Scholar
• Thomas JW, Kendall PL, Mitchell HG. The natural autoantibody repertoire of nonobese diabetic mice is highly active. J Immunol 2002;169:6617-24
   PubMed Web of Science ®Google Scholar
• Kendall PL, Moore DJ, Hulbert C, Reduced diabetes in btk-deficient nonobese diabetic mice and restoration of diabetes with provision of an anti-insulin IgH chain transgene. J Immunol 2009;183:6403-12
   PubMed Web of Science ®Google Scholar
• Carratu R, Secondulfo M, de Magistris L, Altered intestinal permeability to mannitol in diabetes mellitus type I. J Pediatr Gastroenterol Nutr 1999;28:264-9
   PubMed Web of Science ®Google Scholar
• Sapone A, de Magistris L, Pietzak M, Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 2006;55:1443-9
   PubMed Web of Science ®Google Scholar
• Cronin CC, Shanahan F. Insulin-dependent diabetes mellitus and coeliac disease. Lancet 1997,349:1096-7
   PubMed Web of Science ®Google Scholar
• Elliott RB, Reddy SN, Bibby NJ, Dietary prevention of diabetes in the non-obese diabetic mouse. Diabetologia 1988;31:62-4
   PubMed Web of Science ®Google Scholar
• Alam C, Valkonen S, Palagani V, Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change. Diabetes 2010;59:2237-46
   Google Scholar
• Turley SJ, Lee JW, Dutton-Swain N, Endocrine self and gut non-self intersect in the pancreatic lymph nodes. Proc Natl Acad Sci USA 2005;102:17729-33
   PubMed Web of Science ®Google Scholar
• Alam C, Valkonen S, Ohls S, Enhanced trafficking to the pancreatic lymph nodes and auto-antigen presentation capacity distinguishes peritoneal B lymphocytes in non-obese diabetic mice. Diabetologia 2010;53:346-55
   PubMedGoogle Scholar
• Ha SA, Tsuji M, Suzuki K, Regulation of B1 cell migration by signals through Toll-like receptors. J Exp Med 2006;203:2541-50
   PubMed Web of Science ®Google Scholar
• Griffin DO, Holodick NE, Rothstein TL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70–. J Exp Med 2011;208:67-80
   PubMed Web of Science ®Google Scholar
• Yu S, Maiti PK, Dyson M, B cell-deficient NOD.H-2h4 mice have CD4+CD25+ T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis. J Exp Med 2006;203:349-58
   PubMed Web of Science ®Google Scholar
• Mauri C, Blair PA. Regulatory B cells in autoimmunity: developments and controversies. Nat Rev Rheumatol 2010;6:636-43
   PubMed Web of Science ®Google Scholar
• Gray D, Gray M. What are regulatory B cells? Eur J Immunol 2010;40:2677-9
   PubMed Web of Science ®Google Scholar
• Agarwal A, Vieira CA, Book BK, Rituximab, anti-CD20, induces in vivo cytokine release but does not impair ex vivo T-cell responses. Am J Transplant 2004;4:1357-60
   PubMed Web of Science ®Google Scholar
• Norman DJ, Chatenoud L, Cohen D, Consensus statement regarding OKT3-induced cytokine-release syndrome and human antimouse antibodies. Transplant Proc 1993;25:89-92
   PubMed Web of Science ®Google Scholar
• Hamaguchi Y, Uchida J, Cain DW, The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice. J Immunol 2005;174:4389-99
   PubMed Web of Science ®Google Scholar
• Herbst R, Wang Y, Gallagher S, B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody. J Pharmacol Exp Ther 2010;335:213-22
   PubMed Web of Science ®Google Scholar
• Uchida J, Hamaguchi Y, Oliver JA, The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J Exp Med 2004;199:1659-69
   PubMed Web of Science ®Google Scholar
• Gaglia JL, Guimaraes AR, Harisinghani M, Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest 2011;121:442-5
   PubMed Web of Science ®Google Scholar